Array
(
[id] => 1413
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1413.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In postoperative anaemia with Hb less than 10 g/dl, we recommend timely i.v. iron administration at weightbased dosing after considering contraindications.(Evidence level: moderate;Recommendation grade: strong)
[laiyuan] => 对于术后血红蛋白低于10 g/dl的贫血患者,我们建议在考虑禁忌症后,按照体重剂量及时静脉注射铁剂。(证据级别:中;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于术后血红蛋白低于10 g/dl的贫血患者,我们建议在考虑禁忌症后,按照体重剂量及时静脉注射铁剂。(证据级别:中;推荐强度:强推荐)
In postoperative anaemia with Hb less than 10 g/dl, we recommend timely i.v. iron administration at weightbased dosing after considering contraindications.(Evidence level: moderate;Recommendation grade: strong)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1414
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1414.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In postoperative anaemia with Hb less than 6 to 8 g/dl or falling below physiological RBC transfusion triggers (based on signs of organ ischaemia and adequacy of cardiopulmonary reserve), we recommend RBC transfusion with a single unit strategy.(Evidence level: low;Recommendation grade: strong)
[laiyuan] => 对于术后血红蛋白低于6-8g/dl或低于生理性红细胞输注触发点(基于器官缺血体征和心肺储备充足)的贫血,我们推荐单一单位输注红细胞策略。(证据级别:低;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于术后血红蛋白低于6-8g/dl或低于生理性红细胞输注触发点(基于器官缺血体征和心肺储备充足)的贫血,我们推荐单一单位输注红细胞策略。(证据级别:低;推荐强度:强推荐)
In postoperative anaemia with Hb less than 6 to 8 g/dl or falling below physiological RBC transfusion triggers (based on signs of organ ischaemia and adequacy of cardiopulmonary reserve), we recommend RBC transfusion with a single unit strategy.(Evidence level: low;Recommendation grade: strong)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1415
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1415.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => For postoperative iron administration, we recommend i.v.over oral iron administration. (Evidence level: moderate;Recommendation grade: strong)
[laiyuan] => 对于术后补铁,我们建议静脉补铁,而不是口服补铁。(证据级别:中;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于术后补铁,我们建议静脉补铁,而不是口服补铁。(证据级别:中;推荐强度:强推荐)
For postoperative iron administration, we recommend i.v.over oral iron administration. (Evidence level: moderate;Recommendation grade: strong)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1416
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1416.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Intravenous iron formulations allowing higher maximal single doses (such as isomaltoside ,carboxymaltose) may be more effective than those with low licensed maximum single doses (such as sucrose). (Evidence level: moderate)
[laiyuan] => 单次最大剂量较高的静脉注射铁制剂(如异麦芽糖苷、羧甲基麦芽糖)可能比单次最大剂量较低的制剂(如蔗糖)更有效。(证据级别:中)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
单次最大剂量较高的静脉注射铁制剂(如异麦芽糖苷、羧甲基麦芽糖)可能比单次最大剂量较低的制剂(如蔗糖)更有效。(证据级别:中)
Intravenous iron formulations allowing higher maximal single doses (such as isomaltoside ,carboxymaltose) may be more effective than those with low licensed maximum single doses (such as sucrose). (Evidence level: moderate)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1417
[catid] => 105
[title] => 中国甲状腺及甲状旁腺手术中神经监测指南(2023版)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1417.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://kns-cnki-net-443.webvpn.gszy.edu.cn/kcms2/article/abstract?v=VoBN4ANGQ4fbgf_0S6_dkvGZ7foV9Ru3ICVKer-DhhDaSeUQuW0DmjoX2jYJwOw4R5iNGN7SddutlTXABllFSJqHzwNPHSQvGxfkVvoTx2qEpsWnqWStCZ37iROGZMfOzDc_DilA8EQ=&uniplatform=NZKPT&flag=copy
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => 中国医师协会
中国研究型医院学会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 肌松剂应选用中短效非去极化类型,麻醉诱导时通常给予1倍ED95剂量或可适量增加,术中不宜或仅可少量追加,必要时可使用拮抗剂减弱肌松作用,以免影响神经监测效果。(推荐等级A;证据等级:A)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
肌松剂应选用中短效非去极化类型,麻醉诱导时通常给予1倍ED95剂量或可适量增加,术中不宜或仅可少量追加,必要时可使用拮抗剂减弱肌松作用,以免影响神经监测效果。(推荐等级A;证据等级:A)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:中国医师协会
中国研究型医院学会
Array
(
[id] => 1418
[catid] => 105
[title] => 中国甲状腺及甲状旁腺手术中神经监测指南(2023版)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1418.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://kns-cnki-net-443.webvpn.gszy.edu.cn/kcms2/article/abstract?v=VoBN4ANGQ4fbgf_0S6_dkvGZ7foV9Ru3ICVKer-DhhDaSeUQuW0DmjoX2jYJwOw4R5iNGN7SddutlTXABllFSJqHzwNPHSQvGxfkVvoTx2qEpsWnqWStCZ37iROGZMfOzDc_DilA8EQ=&uniplatform=NZKPT&flag=copy
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => 中国医师协会
中国研究型医院学会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 麻醉管理中可使用抗胆碱药物减少腺体分泌,有助于保持表面电极与声带的良好接触。(推荐等级:B;证据等级:C)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
麻醉管理中可使用抗胆碱药物减少腺体分泌,有助于保持表面电极与声带的良好接触。(推荐等级:B;证据等级:C)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:中国医师协会
中国研究型医院学会
Array
(
[id] => 1419
[catid] => 14
[title] => 中国甲状腺及甲状旁腺手术中神经监测指南(2023版)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1419.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://kns-cnki-net-443.webvpn.gszy.edu.cn/kcms2/article/abstract?v=VoBN4ANGQ4fbgf_0S6_dkvGZ7foV9Ru3ICVKer-DhhDaSeUQuW0DmjoX2jYJwOw4R5iNGN7SddutlTXABllFSJqHzwNPHSQvGxfkVvoTx2qEpsWnqWStCZ37iROGZMfOzDc_DilA8EQ=&uniplatform=NZKPT&flag=copy
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => 中国医师协会
中国研究型医院学会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 宜在可视喉镜下留置监测导管,避免使用导管表面润滑油和喉腔喷雾,注意置管角度与深度,确保表面电极与声带接触良好。(推荐等级:A;证据等级:C)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
宜在可视喉镜下留置监测导管,避免使用导管表面润滑油和喉腔喷雾,注意置管角度与深度,确保表面电极与声带接触良好。(推荐等级:A;证据等级:C)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:中国医师协会
中国研究型医院学会
Array
(
[id] => 1420
[catid] => 14
[title] => 中国甲状腺及甲状旁腺手术中神经监测指南(2023版)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1420.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://kns-cnki-net-443.webvpn.gszy.edu.cn/kcms2/article/abstract?v=VoBN4ANGQ4fbgf_0S6_dkvGZ7foV9Ru3ICVKer-DhhDaSeUQuW0DmjoX2jYJwOw4R5iNGN7SddutlTXABllFSJqHzwNPHSQvGxfkVvoTx2qEpsWnqWStCZ37iROGZMfOzDc_DilA8EQ=&uniplatform=NZKPT&flag=copy
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => 中国医师协会
中国研究型医院学会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 术前宜进行喉镜检查或其他检查评估声带功能,术后可视情况选择性应用。(推荐等级:A;证据等级:B)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前宜进行喉镜检查或其他检查评估声带功能,术后可视情况选择性应用。(推荐等级:A;证据等级:B)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:中国医师协会
中国研究型医院学会
Array
(
[id] => 1421
[catid] => 105
[title] => 中国甲状腺及甲状旁腺手术中神经监测指南(2023版)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1421.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:33
[updatetime] => 2024-01-11 15:24:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://kns-cnki-net-443.webvpn.gszy.edu.cn/kcms2/article/abstract?v=VoBN4ANGQ4fbgf_0S6_dkvGZ7foV9Ru3ICVKer-DhhDaSeUQuW0DmjoX2jYJwOw4R5iNGN7SddutlTXABllFSJqHzwNPHSQvGxfkVvoTx2qEpsWnqWStCZ37iROGZMfOzDc_DilA8EQ=&uniplatform=NZKPT&flag=copy
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => 中国医师协会
中国研究型医院学会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 肌松剂过量时,可暂停涉及神经区域的手术操作或应用拮抗剂,待肌松效果减弱后再行手术操作。(推荐等级:A;证据等级:A)
[znzldj] => B
[_inputtime] => 1704957873
[_updatetime] => 1704957873
[_nrjc] =>
[_nrsh] =>
)
推荐意见
肌松剂过量时,可暂停涉及神经区域的手术操作或应用拮抗剂,待肌松效果减弱后再行手术操作。(推荐等级:A;证据等级:A)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:中国医师协会
中国研究型医院学会
Array
(
[id] => 1381
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1381.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:32
[updatetime] => 2024-01-11 15:24:32
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => VHA-guided haemostatic treatment reduces the need for blood products. (Evidence level: moderate)
[laiyuan] => VHA指导下的止血治疗减少了对血液制品的需求。(证据级别:中)
[znzldj] => B
[_inputtime] => 1704957872
[_updatetime] => 1704957872
[_nrjc] =>
[_nrsh] =>
)
推荐意见
VHA指导下的止血治疗减少了对血液制品的需求。(证据级别:中)
VHA-guided haemostatic treatment reduces the need for blood products. (Evidence level: moderate)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens